Neovascularization, Pathologic

"Neovascularization, Pathologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.

Descriptor ID	D009389
MeSH Number(s)	C23.550.589.500
Concept/Terms	Neovascularization, Pathologic Neovascularization, Pathologic Pathologic Neovascularization Neovascularization, Pathological Pathological Neovascularization Pathologic Angiogenesis Angiogenesis, Pathologic Angiogenesis, Pathological Pathological Angiogenesis

Below are MeSH descriptors whose meaning is more general than "Neovascularization, Pathologic".

Diseases [C]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Metaplasia [C23.550.589]
Neovascularization, Pathologic [C23.550.589.500]

Below are MeSH descriptors whose meaning is related to "Neovascularization, Pathologic".

Below are MeSH descriptors whose meaning is more specific than "Neovascularization, Pathologic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neovascularization, Pathologic" by people in this website by year, and whether "Neovascularization, Pathologic" was a major or minor topic of these publications.

Bar chart showing 118 publications over 30 distinct years, with a maximum of 13 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1996	2	1	3
1997	1	0	1
1998	3	0	3
1999	1	0	1
2000	1	1	2
2001	2	0	2
2002	0	2	2
2003	2	2	4
2004	1	2	3
2005	0	7	7
2006	3	1	4
2007	0	3	3
2008	3	10	13
2009	5	3	8
2010	0	5	5
2011	4	8	12
2012	4	2	6
2013	3	3	6
2014	1	2	3
2015	4	1	5
2016	1	2	3
2017	4	0	4
2018	3	2	5
2019	2	3	5
2020	0	2	2
2021	0	1	1
2022	0	1	1
2023	1	0	1
2024	0	2	2

Below are the most recent publications written about "Neovascularization, Pathologic" by people in Profiles.

Sicinska E, Kola VSR, Kerfoot JA, Taddei ML, Al-Ibraheemi A, Hsieh YH, Church AJ, Landesman-Bollag E, Landesman Y, Hemming ML. ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs. Cancer Res. 2024 Jul 15; 84(14):2247-2264.

View in: PubMed
Kim AE, Lou KW, Giobbie-Hurder A, Chang K, Gidwani M, Hoebel K, Patel JB, Cleveland MC, Singh P, Bridge CP, Ahmed SR, Bearce BA, Liu W, Fuster-Garcia E, Lee EQ, Lin NU, Overmoyer B, Wen PY, Nayak L, Cohen JV, Dietrich J, Eichler A, Heist R, Krop I, Lawrence D, Ligibel J, Tolaney S, Mayer E, Winer E, Perrino CM, Summers EJ, Mahar M, Oh K, Shih HA, Cahill DP, Rosen BR, Yen YF, Kalpathy-Cramer J, Martinez-Lage M, Sullivan RJ, Brastianos PK, Emblem KE, Gerstner ER. Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance. Neuro Oncol. 2024 05 03; 26(5):965-974.

View in: PubMed
Ferkowicz MJ, Verma A, Barwinska D, Melo Ferreira R, Henderson JM, Kirkpatrick M, Silva PS, Steenkamp DW, Phillips CL, Waikar SS, Sutton TA. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2024 Feb 01; 19(2):266-275.

View in: PubMed
Corvera S, Solivan-Rivera J, Yang Loureiro Z. Angiogenesis in adipose tissue and obesity. Angiogenesis. 2022 11; 25(4):439-453.

View in: PubMed
Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, Fahr N, Desbuisson M, Grimm A, Zhang H, Chong C, Dagher J, Chee S, Tsianou T, Dorier J, Stevenson BJ, Iseli C, Ronet C, Bobisse S, Genolet R, Walton J, Bassani-Sternberg M, Kandalaft LE, Ren B, McNeish I, Swisher E, Harari A, Delorenzi M, Ciriello G, Irving M, Rusakiewicz S, Foukas PG, Martinon F, Dangaj Laniti D, Coukos G. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021 07 20; 36(3):109412.

View in: PubMed
Peviani M, Spano G, Pagani A, Brugnara G, Covino C, Galli R, Biffi A, Politi LS. Lipophilic dye-compatible brain clearing technique allowing correlative magnetic resonance/high-resolution fluorescence imaging in rat models of glioblastoma. Sci Rep. 2020 10 21; 10(1):17974.

View in: PubMed
Loretelli C, Ben Nasr M, Giatsidis G, Bassi R, Lancerotto L, D'Addio F, Valderrama-Vasquez A, Scherer SS, Salvatore L, Madaghiele M, Abdelsalam A, Ippolito E, Assi E, Usuelli V, El Essawy B, Sannino A, Pietramaggiori G, Zuccotti GV, Orgill DP, Fiorina P. Embryonic stem cell extracts improve wound healing in diabetic mice. Acta Diabetol. 2020 Jul; 57(7):883-890.

View in: PubMed
Gagliardi F, Narayanan A, Gallotti AL, Pieri V, Mazzoleni S, Cominelli M, Rezzola S, Corsini M, Brugnara G, Altabella L, Politi LS, Bacigaluppi M, Falini A, Castellano A, Ronca R, Poliani PL, Mortini P, Galli R. Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis. Neurobiol Dis. 2020 02; 134:104705.

View in: PubMed
Labadie BW, Liu P, Bao R, Crist M, Fernandes R, Ferreira L, Graupner S, Poklepovic AS, Duran I, Maleki Vareki S, Balar AV, Luke JJ. BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma. J Transl Med. 2019 11 25; 17(1):386.

View in: PubMed
Mercurio AM. VEGF/Neuropilin Signaling in Cancer Stem Cells. Int J Mol Sci. 2019 Jan 23; 20(3).

View in: PubMed

People

Explore

Similar Concepts

Top Journals